I nduction of systemic immunity to tumor cells is one of the therapeutic strategies for cancer. Recent studies have shown that the expression of cytokine gene(s) in tumor cells can elicit an immune response to the cytokine producers; consequently, the tumor cells can be eliminated from host animals. 1 Although the precise mechanisms regarding the rejection of tumors have not been characterized fully, 2 clinical trials using cytokineproducing tumor cells as a tumor vaccine have been approved. 3 Among the cytokines tested, interleukin-2 (IL-2) has been extensively studied in various experimental models, and the possibility of vaccination using IL-2 producer cells is under investigation. 4 IL-15 is a novel cytokine that promotes the growth of T cells, 5, 6 natural killer (NK) cells, [7] [8] [9] [10] and B cells.
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Although it displays no sequence homology with IL-2, 12 IL-15 requires both the ␤-and ␥-chain of the IL-2 receptor for its binding and signal transduction. 13 Therefore, IL-15 and IL-2 may have an overlapped signaling system. 14 Recently, a human IL-15-specific ␣ subunit gene has been cloned, 15 and this subunit is responsible for the high-affinity binding of IL-15. 15 Cellular distribution of the ␣ subunit is much wider than that of the IL-2 receptor ␣ subunit. 15 This finding suggests that there is a broader target cell range for IL-15 and differential biological significance between IL-2 and IL-15. In this study, we tested whether the expression of IL-15 gene in tumor cells could evoke immune responses in immunocompetent and immunocompromised host animals.
MATERIALS AND METHODS

Cells and animals
BALB/c and BALB/c nu/nu mice (6-to 8-week-old females) were purchased from the Shizuoka Laboratory Animal Center (Hamamatsu, Japan); BALB/c scid/scid mice (6-to 8-week-old females) were obtained from Nippon Clea (Tokyo, Japan). Colon 26, a carcinogen-induced undifferentiated adenocarcinoma cell line, 16, 17 was provided by Dr. J. Hamuro (Ajinomoto, Tokyo, Japan). Both ecotropic 2 and amphotropic PA317 packaging cells were obtained from the American Type Culture Collection (Manassas, Va). These cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf sera.
Isolation of murine IL-15 cDNA
The reverse transcription-based polymerase chain reaction (PCR) method was used to clone murine IL-15 cDNA. Poly(A ϩ ) mRNA was extracted from lipopolysaccharide (10 g/mL)-stimulated spleen cells of BALB/c mice, and synthesized first-strand cDNAs were amplified with two primers, 5Ј-AT-TACTCGAGCCATAGCCAGCTCATCTTCAAC-3Ј (as a 5Ј primer) and 5Ј-ACTACTCGAGAGCAGGTGGAGGTACCT-TAATAAC-3Ј (as a 3Ј primer). Amplification was performed according to the manufacturer's recommendations (Perkin-Elmer Cetus, Norwalk, Conn) and consisted of 30 cycles under the following conditions: 1 minute at 94°C for denaturation, 1 minute at 59°C for primer annealing, and 2 minutes at 72°C for primer extension. The sequence of the PCR product was confirmed to be identical with the published sequence of C57BL/6 mice-derived IL-15 cDNA 18 except for two nucleotides in the 3Ј-untranslational region. The nucleotide substitutions are probably due to the polymorphism between the mouse strains. 19 was used to harbor cloned IL-15 cDNA. The vector DNA with IL-15 cDNA was transfected into ecotropic 2 cells using lipofectin reagent (Life Technologies, Gaithersburg, Md); after the drug selection with G418 (400 g/mL, Life Technologies), cell-free supernatants of G418-resistant clones were used as a retrovirus stock. The culture supernatants containing retrovirus were incubated with amphotropic PA317 cells in the presence of 8 g/mL polybrene (Aldrich, Milwaukee, Wis) for infection. Among the G418-resistant PA317 cells, a clone that produced the largest amount of IL-15 mRNA was selected, and the culture supernatants were used for infecting Colon 26 cells. G418 (400 g/mL)-resistant Colon 26 cells were cloned and used for experiments. . In an experiment for the depletion of asialo GM 1 -positive cells, BALB/c nude mice were injected i.p. with anti-asialo GM 1 Ab (100 g/mice, Wako, Osaka, Japan) 1 day before the inoculation of tumor cells. 20 
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Immunohistochemical study
Sections (4-or 5-m thickness) from frozen tumors were reacted with anti-CD11b, anti-CD90, or anti-CD31 Ab (PharMingen). Next, they were reacted with biotinylated secondary Ab. The staining using avidin-conjugated horseradish peroxidase was performed according to the manufacturer's instructions (Vector Laboratories, Burlingame, Calif). Table 1 ). In contrast, wt tumors grew continuously and all of the inoculated mice died. In an experiment of i.p. inoculation, the survival of the mice injected with Colon 26/ IL-15 cells was significantly prolonged compared with that of the mice inoculated with wt cells (Table 1, 2 ϭ 14.6, df ϭ 1, P Ͻ .01). Some of the mice died due to i.p. disseminations of the tumors, but the rest of the mice survived without any signs of tumor burdens. In a model of experimental lung metastasis caused by i.v. injection of tumor cells, the survival of the mice injected with Colon 26/IL-15 cells was not different from that of the mice injected with wt cells ( inoculated with wt cells (Table 2 , P ϭ .135). Thus, any specific types of cells were not primarily responsible for the growth suppression of wt cells. The nude mice that were inoculated with Colon 26/IL-15 cells developed tumors, but the growth was markedly retarded compared with that of wt cells (Fig  1) . Consequently, the survival days were longer compared with the nude mice injected with wt cells (Table 2 
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01). Thus, ␥␦ T cells, NK1
ϩ T cells, 21 and/or B cells that are absent in SCID mice are also involved in the antitumor activity.
To examine the involvement of NK cells, nude mice were treated with anti-asialo GM 1 Ab and subsequently inoculated with wt or Colon 26/IL-15 cells. The survival of the mice treated with the Ab was not statistically different from that of the Ab-untreated mice, irrespective of cell types inoculated ( (Fig 2A) but not into wt tumors in immunocompetent mice (Fig 2B) . Migration of CD31
ϩ cells was also observed in Colon 26/IL-15 tumors developed in nude and SCID mice (Fig 2, C-F) , although the level of cell migration was not comparable with that seen in immunocompetent mice. The infiltration of CD11b ϩ cells into the Colon 26/IL-15 tumors that developed in immunocompetent mice was heavier than that into wt tumors (Fig 2, G and H) . However, the infiltration was not observed in immunocompromised mice irrespective of the inoculated cells. The accumulation of CD90 ϩ cells into Colon 26/IL-15 tumors in immunocompetent mice was more significant than that into wt tumors (Fig 2, I and J), but the accumulation level was not markedly different between the Colon 26/IL-15 and wt tumors that developed in immunocompromised mice (data not shown).
DISCUSSION
In this study, we examined the antitumor effect of the IL-15 secreted from tumor cells. Syngeneic immunocompetent mice that were inoculated s.c. with Colon 26/IL-15 cells developed small tumors; however, these tumors regressed spontaneously. Protective immunity was generated in the mice that had rejected Colon 26/IL-15 cells, and this systemic immunity was effective for eradicating wt cells subsequently challenged even in the experimental lung metastasis model (see below). The protective immunity was also tumor-specific, because the mice that had rejected Colon 26/IL-15 cells developed tumors of syngeneic fibrosarcoma Meth A cells or lymphoma RL1 cells (data not shown).
Routes of inoculation influenced the antitumor effect caused by Colon 26/IL-15 cells. Colon 26/IL-15 cells inoculated s.c. were completely rejected, whereas i.v. injected Colon 26/IL-15 cells generated multiple lung metastatic foci. The number of lung foci was the same as that seen in mice injected with wt cells (data not shown); consequently, the survival of the mice injected with Colon 26/IL-15 cells was not statistically different from that of the mice injected with wt cells (Table 1) . Injection of smaller numbers of cells also produced lung foci, and the numbers of foci between the Colon 26/IL-15 and wt cell-injected groups were not different irrespective of the numbers of cells injected (data not shown). The antitumor effect induced by i.p. injection was intermediate, because some of the mice could survive without i.p. dissemination (Table 1) . Differential antitumor effects depending upon the inoculation routes were not characterized in this study. We speculate that in the s.c. inoculation, professional Ag-presenting cells such as dendritic cells migrated more efficiently into the tumor cells than in other experimental models. This enhanced Ag processing of putative tumor Ag(s) facilitates the generation of systemic immunity. It has been shown in our previous studies and in other studies that the generation of antitumor immunity by i.v. injection was more difficult than that by s.c. inoculation. 22, 23 Experiments using immunocompromised mice showed that the antitumor effect caused by Colon 26/ IL-15 cells was influenced by the immunocompetency of the host. Recent investigations stress the importance of IL-15 in the generation of NK cells 9 and in the enhancement of the cytotoxic activity of NK cells.
7 IL-15 also plays an important role in the production of interferon-␥ (IFN-␥) from NK cells. 24 In addition, IL-15 can induce lymphokine-activated killer cells and cytotoxic T cells. 7, 12 In the present study, however, we showed that the depletion of asialo GM 1 -positive NK cells from nude mice did not affect the survival of the mice inoculated with Colon 26/IL-15 cells (Table 2) . Immunohistochemical staining did not reveal DX5 (pan-NK marker)-positive cells 25 Because the survival of the SCID mice inoculated with Colon 26/IL-15 cells was shorter than that of the nude mice, ␥␦ T cells, NK1 ϩ T cells, and/or B cells that are not generated in SCID mice also play a certain role in the antitumor effect. In fact, IL-15 is a growth factor for ␥␦ T cells and stimulates the production of IFN-␥ from ␥␦ T cells. 6 IL-15 also has the ability to induce B-cell proliferation. 11 In contrast, the expression of the IL-15 receptor on NK1 ϩ T cells and the biological activities of IL-15 on NK1 ϩ T cells have not been analyzed. The survival of the SCID mice inoculated with Colon 26/ IL-15 cells was prolonged in comparison with that of SCID mice injected with wt cells. This observation suggests that granulocytes and/or macrophages are also involved in the IL-15-mediated antitumor effect. The immunohistochemical study revealed that CD31 ϩ cells, which were distinguished from CD31 ϩ vascular endothelium, infiltrated into the tumors of Colon 26/IL-15 cells that developed not only in immunocompetent mice but in immunocompromised mice (Fig 2, A, C , and E). In contrast, the migration of CD11b ϩ cells and CD90 ϩ cells into Colon 26/IL-15 tumors, which was observed in immunocompetent mice (Fig 2, G and I) , was not evident in immunocompromised mice (data not shown). Infiltrated cells cannot be directly linked with their roles in defense mechanisms; however, the present study suggests that CD31 ϩ granulocytes and/or macrophages contribute to the IL-15-mediated antitumor effects in immunocompromised hosts and may also play a role in Ag presentation in immunocompetent hosts.
The translational regulation of the murine IL-15 gene is influenced by the mechanism of alternative splicing. Deletion of exon 2 and alternatively spliced exon 5 up-regulated the translational product. 26 Because our IL-15 cDNA derived from PCR is devoid of exon 2 but contains nonalternatively sliced exon 5, the production of IL-15 in Colon 26 cells can be increased by modifying the cDNA. Secretion of IL-15 is also regulated at the translational or posttranslational level. 27 The mechanism of IL-15 secretion is not well characterized; however, a certain amount of IL-15 was detected in the supernatants of Colon 26/IL-15 cells, and its antitumor effect was dependent upon the amount of IL-15 secreted ( Table 1) . Further investigation is necessary to analyze the regulatory mechanism concerning IL-15 production, because recently identified IL-18, for example, needs caspase I protease to be processed. 28, 29 In our previous study, we showed an antitumor effect with IL-2-producing Colon 26 cells. 30 Inoculation of IL-2-producing Colon 26 cells into syngeneic immunocompetent mice did not result in s.c. tumors, and protective immunity was generated in the mice. However, we did not observe the antitumor effect with IL-2 producers in nude mice. The differential antitumor effects caused by IL-2 or IL-15 producer cells may be due to distinct kinds of cells activated by the cytokines. It has been reported that IL-15 can cooperate with IL-12 or IL-2 to proliferate NK cells and to induce IFN-␥ secretion. 31, 32 Therefore, it is worthwhile to test the combinatory expression of these cytokines for its efficacy in inducing antitumor effects.
